Total Payments
$4,005
2024 Payments
$307.80
Companies
28
Transactions
241
Medicare Patients
3,561
Medicare Billing
$476,018
Payment Breakdown by Category
Food & Beverage$4,005 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,005 | 241 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $801.77 | 51 | $0 (2024) |
| GlaxoSmithKline, LLC. | $502.33 | 26 | $0 (2024) |
| MannKind Corporation | $408.82 | 23 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $316.84 | 21 | $0 (2024) |
| PFIZER INC. | $310.79 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $183.81 | 13 | $0 (2023) |
| Amarin Pharma Inc. | $118.21 | 7 | $0 (2022) |
| Xeris Pharmaceuticals, Inc. | $116.94 | 7 | $0 (2022) |
| ABBVIE INC. | $113.14 | 7 | $0 (2024) |
| Merck Sharp & Dohme LLC | $111.49 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $307.80 | 16 | Novo Nordisk Inc ($77.71) |
| 2023 | $172.07 | 10 | Novo Nordisk Inc ($74.47) |
| 2022 | $527.47 | 30 | PFIZER INC. ($121.69) |
| 2021 | $618.03 | 38 | Novo Nordisk Inc ($120.69) |
| 2020 | $652.22 | 35 | GlaxoSmithKline, LLC. ($190.39) |
| 2019 | $629.39 | 41 | Mannkind Corporation ($165.12) |
| 2018 | $656.78 | 37 | Novo Nordisk Inc ($179.99) |
| 2017 | $441.25 | 34 | Novo Nordisk Inc ($120.77) |
All Payment Transactions
241 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Obesity | ||||||
| 10/02/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.63 | General |
| 08/28/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Respiratory | ||||||
| 05/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Diabetes | ||||||
| 04/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes | ||||||
| 02/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Oncology | ||||||
| 02/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: PSYCHIATRY | ||||||
| 01/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: RESPIRATORY | ||||||
| 11/30/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Oncology | ||||||
| 11/01/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.65 | General |
| 10/23/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: RESPIRATORY | ||||||
| 10/20/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Obesity | ||||||
| 08/23/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.28 | General |
| 08/23/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/12/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Gastroenterology | ||||||
| 06/14/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Gastroenterology | ||||||
| 03/23/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 857 | 2,401 | $265,236 | $135,961 |
| 2022 | 16 | 991 | 1,917 | $239,441 | $133,879 |
| 2021 | 9 | 750 | 1,184 | $170,626 | $97,186 |
| 2020 | 11 | 963 | 1,511 | $220,132 | $108,992 |
Total Patients
3,561
Total Services
7,013
Medicare Billing
$476,018
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 336 | $55,670 | $28,913 | 51.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 88 | 139 | $29,764 | $17,458 | 58.7% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 60 | 559 | $33,540 | $16,240 | 48.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 63 | 458 | $34,350 | $16,099 | 46.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 57 | 355 | $28,400 | $12,538 | 44.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 98 | 98 | $17,150 | $12,116 | 70.6% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 16 | 16 | $21,545 | $10,030 | 46.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 113 | $13,695 | $6,582 | 48.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 73 | 108 | $12,662 | $6,537 | 51.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 44 | 67 | $10,720 | $5,555 | 51.8% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 13 | 14 | $2,890 | $1,980 | 68.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 100 | 109 | $2,725 | $1,121 | 41.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 13 | $1,085 | $517.92 | 47.7% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 16 | 16 | $1,040 | $273.34 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 161 | 365 | $58,400 | $31,147 | 53.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 83 | 170 | $36,550 | $22,547 | 61.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 96 | 96 | $16,800 | $12,168 | 72.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 96 | 172 | $18,836 | $10,822 | 57.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 102 | 173 | $19,775 | $10,230 | 51.7% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2022 | 14 | 14 | $18,340 | $9,551 | 52.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 58 | 99 | $15,840 | $9,085 | 57.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 62 | 200 | $16,000 | $8,239 | 51.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 60 | 213 | $15,975 | $8,075 | 50.5% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 56 | 192 | $11,520 | $5,969 | 51.8% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2022 | 11 | 11 | $2,200 | $1,725 | 78.4% |
About Dr. Carmen Bautista Dator, MD
Dr. Carmen Bautista Dator, MD is a Internal Medicine healthcare provider based in Oswego, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346267291.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carmen Bautista Dator, MD has received a total of $4,005 in payments from pharmaceutical and medical device companies, with $307.80 received in 2024. These payments were reported across 241 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($4,005).
As a Medicare-enrolled provider, Bautista Dator has provided services to 3,561 Medicare beneficiaries, totaling 7,013 services with total Medicare billing of $476,018. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Oswego, NY
- Active Since 07/16/2006
- Last Updated 03/05/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346267291
Products in Payments
- AFREZZA (Drug) $408.82
- Ozempic (Drug) $357.19
- SHINGRIX (Biological) $222.98
- TRELEGY ELLIPTA (Drug) $195.24
- ENTRESTO (Drug) $171.00
- ELIQUIS (Drug) $121.69
- Victoza (Drug) $118.46
- Vascepa (Drug) $118.21
- FARXIGA (Drug) $110.45
- Tresiba (Drug) $105.83
- Livalo (Drug) $105.52
- NUZYRA (Drug) $103.68
- SYMBICORT (Drug) $99.51
- PREVNAR 13 (Biological) $87.77
- KEVEYIS (Drug) $75.89
- Rybelsus (Drug) $72.15
- JANUVIA (Drug) $68.07
- XIFAXAN (Drug) $61.74
- JARDIANCE (Drug) $58.00
- BREO (Drug) $56.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Oswego
Padma Ram, Md, MD
Internal Medicine — Payments: $13,097
Internal Medicine $13,097
Dr. Carlos Dator, Md, MD
Internal Medicine — Payments: $4,679
Internal Medicine $4,679
Dr. Matthew Liepke, M.d, M.D
Internal Medicine — Payments: $3,419
Internal Medicine $3,419
David Bass, Do, DO
Internal Medicine — Payments: $1,150
Internal Medicine $1,150
Dr. Aaysha Kapila, M.d, M.D
Internal Medicine — Payments: $624.85
Internal Medicine $624.85
Dr. Alexis Dunne, Md, MD
Internal Medicine — Payments: $621.78
Internal Medicine $621.78